Industry satellite symposiums
Satellite symposium at the 4th World Congress of Cutaneous Lymphomas
Wednesday, 12 February 2020
Time: 16:15h – 16.45h
Room: Auditori – Plenary Room
Title
Management of chlormethine gel-induced dermatitis: a case-based discussionSpeaker
ChairBrian Poligone, MD, PhD
Medical Director
Rochester Skin Lymphoma Medical Group
Fairport, NY, USA
Program
16:00–16:05 Opening and welcome
Brian Poligone, MD, PhD (USA)
16:05–16:25 Management of chlormethine gel-induced dermatitis: a case-based discussion
Brian Poligone, MD, PhD (USA)
16:25–16:30 Q&A and closing
Brian Poligone, MD, PhD (USA)
- Thursday, 13 February 2020
Time: 15:30h – 16.00h
Room: Auditori – Plenary Room
CLINICAL IMPORTANCE OF ASSESSING BLOOD INVOLVEMENT IN CTCL
TITLE
PROGRAMME:
Welcome and introduction
Maarten Vermeer, MD, PhD
Leiden University Medical Centre (LUMC), Leiden, Netherlands
Standardizing the measurement of blood involvement in CTCL patients
Maarten Vermeer, MD, PhD
Stephen L. Morris, MBBS, MRCP, FRCR
Guy’s and St Thomas’ NHS Foundation Trust, London, UK
What is the prognostic relevance and treatment implications of blood involvement in advanced and less advanced CTCL?
Maarten Vermeer, MD, PhD
Stephen L. Morris, MBBS, MRCP, FRCR
Discussion and conclusions
Maarten Vermeer, MD, PhD
Stephen L. Morris, MBBS, MRCP, FRCR - Friday, 14 February 2020
Time: 13:15h -14:15h
Room: Auditori – Plenary Room
CURRENT TREATMENT PATTERNS AND TARGETED AGENTS IN THE MANAGEMENT OF CTCL
TITLE
PROGRAMME:
13:15–13:20 Welcome and introductions
Prof. Pablo Ortiz RomeroHospital Universitario 12 de Octubre, Madrid, Spain
13:20–13:35 Contemporary European treatment patterns and responses in relapsed/refractory CTCL
Prof. Pablo Ortiz Romero
13:35–13:50 Recently approved targeted agents in the management of CTCL
Prof. Julia ScarisbrickQueen Elizabeth Hospital, Birmingham, UK
13:50–14:10 Sharing clinical practice: real-world case studies
Prof. Julia Scarisbrick, Prof. Pablo Ortiz Romero14:10–14:15 Q&A
Prof. Julia Scarisbrick, Prof. Pablo Ortiz Romero